Barotrauma

Endothelial Biomedicine

Volumn , Issue , 2007, Pages 1239-1247

  Dunn, Winston ^a   Shah, Vijay ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84928855235     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511546198.135     Document Type: Chapter

References (50)

1. Shah V, Kamath P, de Groen P. Physiology of the splanchniccirculation. In: Topol E, Lanzer F, eds. Theory and Practice ofVascularDiseases. Dissertation.University ofMonster,Germany, 2000.
2. Ekataksin W. The isolated artery: an intrahepatic arterial pathwaythat can bypass the lobular parenchyma in mammalian livers.Hepatology. 2000;31(2):269-279.
3. Lautt W. The 1995 Ciba-Geigy Award Lecture. Intrinsic regulationof hepatic blood flow. Can J Pharmacol. 1996;74:223-233.
4. Shah V. Cellular and molecular basis of portal hypertension. ClinLiver Dis. 2001;5:629-644.
5. Rockey DC. The cellular pathogenesis of portal hypertension:stellate cell contractility, endothelin, and nitric oxide. Hepatology.1997;25:2-5.
6. Shah V, Toruner M, Haddad F, et al. Impaired endothelial nitricoxide synthase activity associated with enhanced caveolin bindingin experimental liver cirrhosis. Gastroenterology. 1999;117:1222-1228.
7. Gupta T, Toruner M, Chung M, Groszmann R. Endothelial dysfunctionand decreased production of nitric oxide in the intrahepaticmicrocirculation of cirrhotic rats. Hepatology. 1998;28:926-931.
8. Chatila R, Theise N, Shah V, et al. Caveolin-1 in normal andhuman cirrhotic liver. Gastroenterology. 2000;118:A979.
9. Morales-Ruiz M, Cejudo-Martin P, Fernandez-Varo G, et al.Transduction of the liver with activated Akt normalizes portalpressure in cirrhotic rats. Gastroenterology. 2003;125(2):522-531.
10. Zafra C, Abraldes J, Turnes J, et al. Simvastatin enhances hepaticnitric oxide production and decreases the hepatic vascular tonein patients with cirrhosis. Gastroenterology. 2004;126:749-755.
11. Bellis L, Berzigotti A, Abraldes J, et al. Low doses of isosorbidemononitrate attenuate the postprandial increase in portal pressurein patients with cirrhosis. Hepatology. 2003;37(2):378-384.
12. Fiorucci S, Antonelli E, Tocchetti P, Morelli A. Treatment ofportalhypertensionwithNCX-1000, a liver-specificNOdonor.Areview of its current status. CardiovascDrugRev. 2004;22(2):135-146.
13. Rockey D, Chung J. Regulation of inducible nitric oxide synthaseand nitric oxide during hepatic injury and fibrogenesis. Am JPhysiol. 1997;273:G124-G130.
14. Hori N, Wiest R, Groszmann RJ. Enhanced release of nitric oxidein response to changes in flow and shear stress in the superiormesenteric arteries of portal hypertensive rats.Hepatology. 1998;28:1467-1473.
15. Colombato L, Albillos A, Groszmann R. Temporal relationshipof peripheral vasodilation, plasma volume expansion and thehyperdynamic circulatory state in portal-hypertensive rats. Hepatology.1992;15:323-328.
16. Tsai M, Iwakiri Y, Cadelina G, et al. Mesenteric vasoconstrictiontriggers nitric oxide overproduction in the superior mesentericartery of portal hypertensive rats. Gastroenterology. 2003;125(5):1452-1461.
17. Theodorakis N, Wang Y, Skill N, et al. The role of nitric oxidesynthase isoforms in extrahepatic portal hypertension: studies ingene knock-out mice. Gastroenterology. 2003;124(5):1500-1508.
18. Iwakiri Y, Cadeline G, Sessa W, Groszmann R. Mice with targeteddeletion of eNOS develop hyperdynamic circulation associatedwith portal hypertension. Am J Physiol. 2002;283:G1074-G1081.
19. Rasaratnam B, Connelly N, Chin-Dusting J. Nitric oxide and thehyperdynamic circulation in cirrhosis: is there a role for selectiveintestinal decontamination? Clin Sci (Lond). 2004;107(5):425-434.
20. Chin-Dustin J, Rasaratnam B, Jennings G, Dudley F. Effect of fluoroquinoloneon the enhanced nitric oxide-induced peripheralvasodilation. Ann InternMed. 1997;127:985-988.
21. Albillos A, de la Hera A, Gonzalez M, et al. Increased lipopolysaccharidebinding protein in cirrhotic patients with markedimmune and hemodynamic derangement. Hepatology. 2003;37(1):208-217.
22. Zhang M, Luo B, Chen S-J, et al. Endothelin-1 stimulation ofendothelial nitric oxide synthase in the pathogenesis of hepatopulmonarysyndrome. Am J Physiol. 1999;277(5):G944-G952.
23. Benjaminov F, Prentice M, Sniderman K, et al. Portopulmonaryhypertension in decompensated cirrhosis with refractor ascites.Gut. 2003;52(9):1355-1362.
24. Glyn D. Lascaux and Carnac. London: Butterworth Press, 1965.
25. Bryan C. The Papyrus Ebers (translated from German version). New York: D. Appleton and Company, 1931.
26. Harris C. The Heart and Vascular System in Ancient GreekMedicine; fromAlcmaen toGalen. Oxford: Clarendon Press, 1973.
27. Singer C. Galen on Anatomical Procedures. Translation of survivingbooks with introduction and notes. London:Oxford UniversityPress, 1956.
28. Brock A. Galen on the Natural Faculties (translated from theGreek). London: Loeb Classical Library, 1928.
29. Bradley S. The Splanchnic Circulation. New York: Oxford UniversityPress, 1964.
30. Dobson J. Erasistratus. Proc Roy Soc Med. 1927;20:825-832.
31. Dobson J. Herophilus of Alexandria. Proc Roy SocMed. 1925;18:19-32.
32. Majumdar A. In: Majumdar A, ed. Hand Book of DomesticMedicine and Common Ayurvedic Remedies. New Delhi:Documentation and Publication Division. Central Council forResearch in Ayurveda and Siddha; 1999:88-89.
33. Sprengell C. The Aphorisms of Hippocrates, and the Sentences of Celsus: (with explanations and references to the most considerablewriters in physick and physiology, both ancient and modern: towhich are added,Aphorisms upon the small-pox, measles, and otherdistempers), not so well known to former more temperate ages. London: Printed for R. Bonwick, et al.; 1708.
34. Dawson A. Historical notes on ascites. Gastroenterology. 1960;39:790-791.
35. Runyon B. Historical aspects of treatment of patients with cirrhosisand ascites. Semin Liver Dis. 1997;17:163-173.
36. Reuben A. Out came copious water. Hepatology. 2002;36:261-264.
37. DaVinci L, Vangensteen OC, Windsor Castle RL. RespirazioneCuore, Viscera Addominali. Christiania, Dybwad; 1911.
38. Vesalius A. De humani corporis Fabrica. Basilcae: J. Oporini; 1543.
39. Stahl G. De vena Portae, porta malorum hypochondriaco-splenectico-sufferativo, hysterico-colico hemorrhoidariorum. Halle, 1698.
40. Harvey W. Exercitatio anatomica du motu cordis et sanguinis inanimalibus. Frankfurt:W. Fitzer, 1628.
41. Glisson F. Anatomia Hepatis. London: O. Pullein, 1654.
42. Malpighi M. De viscerum structura excercitatio anatomica. London, 1666.
43. Wepfer J. De dubiis anatomicis. Epistola ad JacobHenricum Paulli.Argentorati: Simonem Paulli, 1665.
44. Malpighi M. Discours anatomiques sur la structure des visceresscavoir du foye, du cerveau, des reins, de la ratte, du polype ducoeur et des poulmons, 2nd Edition. Paris: L. d'Houry, 1687.
45. Banti G. Dell'anemiasplenica.Arch ScuolaAnatPatFirenze. 1883; 124: 53-122.
46. Banti G. La splenomegalia con cirrosi del fegato. Sperimentale.1894; 48: 47-52.
47. Eck N K. Voprosu o perevyazk e vorotno veni. Predvaritelnoyesoobshtsheniye. Voyenno-med. 1877;130:1-2.
48. Myers J, Taylor W. An estimation of portal venous pressure byocclusive catheterization of a hepatic venule. J Clin Invest. 1951;30:662-663.
49. Mc Indoe A.Vascular lesions of portal cirrhosis.ArchPathol. 1928; 5: 23-40.
50. Reuben A, Groszmann R. Portal hypertension: a history. In: Sanyal A, Shah V, eds. Portal Hypertension. Totowa, NJ:HumanaPress, 2005.